Key result
Streptokinase treatment for myocardial infarction led to higher D-dimer levels in the first hour compared to urokinase.
Why the study?
Little is known about fibrinolytic system activation in the days following acute myocardial infarction treated with thrombolytic therapy, a period with high ischaemic recurrence.
Does the coronary anatomical substrate influence late activation of the fibrinolytic system in patients with myocardial infarction treated with thrombolytic therapy?
Cohort (n=41)
Does the coronary anatomical substrate influence late activation of the fibrinolytic system in patients with myocardial infarction treated with thrombolytic therapy?
Late elevation of D-dimer after thrombolysis and heparin withdrawal is associated with occluded or suboccluded infarct-related arteries.
Answers are grounded in this paper and cite their sources.
Streptokinase induces greater early D-dimer rise than urokinase in MI; supports hypothesis that thrombolytic choice influences fibrinolytic timing but leaves clinical relevance open.
Procoagulant activity, thrombin and fibrinolytic system activation have been demonstrated in the first 24-48 h after acute myocardial infarction treated with thrombolytic therapy. Little is known about what happens in the subsequent days, during which the incidence of ischaemic recurrence is high. In 21 patients treated with streptokinase and in 20 patients treated with urokinase we evaluated, with multiple plasma determinations, D-dimer and fibrinogen plasma levels in the first week after myocardial infarction. From the 2nd hour after the beginning of thrombolysis to the 4th day, all patients received intravenous heparin in doses sufficient to raise the partial thromboplastin time to twice its normal level; subcutaneous calcium heparin (12,000 U/day) was subsequently substituted for the intravenous route. Coronary angiography was performed 7 days after infarction. From the basal values 2.22 +/- 1.44 nmol.1(-1) in the streptokinase group and 3.28 +/- 3.05 nmol.1(-1) in the urokinase group, D-dimer rose consistently in the 1st hour after thrombolysis 269.4 +/- 206.7 nmol.1(-1) and 44.5 +/- 35.5 nmol.1(-1) in the streptokinase and urokinase groups, respectively; P < 0.001. After the peak value, which in both groups was reached after 5 h, D-dimer slowly decreased during the study period. It reverted to normal values only in 10/21 patients in the streptokinase group; in the urokinase group normalization was attained in 14/20 patients between the 3rd and 6th days. After withdrawal of i.v. heparin in patients of both groups with TIMI 0 or 1 grade of coronary patency, D-dimer rose to levels four to seven times greater than normal; in patients of both groups with TIMI 2 or 3 grade coronary flow, D-dimer showed a monophasic pattern of progressive normalization (P < 0.05 and P < 0.01 at the 6th and 7th days, respectively, for differences between TIMI 0-1 and TIMI 2-3 groups). After myocardial infarction, thrombolysis is followed by active and persistent fibrin degradation more marked and lasting after streptokinase than after urokinase. When occurring sooner, it is a consequence of plasmin activation induced by thrombolytic agents; later it seems to be related to intracoronary substrate, as suggested by the relationship of plasma elevation of D-dimer with the presence of occluded or suboccluded infarction-related vessels.
No takes yet. Share an insight, caveat, or question.
Salvioni et al. (1996) conducted a cohort in acute myocardial infarction (n=41). Streptokinase vs. Urokinase was evaluated on D-dimer levels in the 1st hour after thrombolysis (p=<0.001). Streptokinase treatment for myocardial infarction led to higher D-dimer levels in the first hour compared to urokinase.
Synapse has enriched 10 related papers. Consider them for comparative context: